Reading List
AstraZeneca signs $555mn AI deal to identify immunology targets (Financial Times) from Techmeme RSS feed.
AstraZeneca signs $555mn AI deal to identify immunology targets (Financial Times)
Financial Times:
AstraZeneca signs $555mn AI deal to identify immunology targets — Pharmaceutical company is latest to invest in artificial intelligence to speed drug development — AstraZeneca has signed a $555mn deal with a San Francisco-based biotech business that specialises in artificial intelligence …